DarioHealth Q1 Sales $5.758M Miss $6.758M Estimate
Portfolio Pulse from Benzinga Newsdesk
DarioHealth (NASDAQ:DRIO) reported Q1 sales of $5.758 million, missing the analyst consensus estimate of $6.758 million by 14.80%. This represents an 18.51% decrease from the same period last year.
May 15, 2024 | 10:33 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
DarioHealth reported Q1 sales of $5.758 million, missing the analyst consensus estimate by 14.80% and showing an 18.51% decrease from the same period last year.
The significant miss on sales estimates and the year-over-year decline in revenue are likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100